Maze Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Welcome everyone to the forty-fourth annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Joyce Zhou, Priyanka Grover, and [Rati Pinhe].
Our next presenting company is MazeTherapeutics, and presenting on behalf of the company, we have CEO Jason Coloma. Jason?
Good morning everyone. I'm Jason Coloma. I'm the CEO of Maze Therapeutics, and first of all I'd like to thank JPMorgan for having us at this year's conference. I'd also like to thank everyone that's in attendance today in the room as well as those listening to the webcast.
As Maze approaches its one year anniversary as a publicly traded company, we are poised for a strong 2026, and I'd also like to thank Anopam and the team for being supportive in our transition to being a public company as we've been benefiting of course from the recent progress that we've been having in terms of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
